Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A Placebo-Controlled, Double-Blind, Parallel-Group, 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects with Early Alzheimer’s Disease Estudio de 24 meses, de grupos paralelos, doble ciego y controlado con placebo para evaluar la eficacia y la seguridad de E2609 en pacientes con enfermedad de Alzheimer temprana https://kusajili.com:443/Trial/Bj8NSLnqxUmlfQ-0owr72A%24a-placebo-controlled-double-blind-parallel-group-24-month-study-to-evaluate-the-efficacy-and-safety-of-e2609-in-subjects-with-e
I have read and accept the terms of use of the site and the Privacy Policy
Send your message